Urticaria and angiedema-like skin reactions in a patient treated with adalimumab

Clinical Rheumatology

Volumn 26, Issue 5, 2007, Pages 787-788

  Nikas, S N ^a   Voulgari, P V ^a   Drosos, A A ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Adalimumab; Antitumor necrosis factor alpha therapy; Rheumatoid arthritis; Urticaria and angiedema

Indexed keywords

ADALIMUMAB; AMLODIPINE; ANTIHISTAMINIC AGENT; C REACTIVE PROTEIN; CALCITONIN; CORTICOSTEROID; CYCLOSPORIN A; HYDROCORTISONE; HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; PREDNISONE;

ADULT; ANAMNESIS; ANGIONEUROTIC EDEMA; ARTICLE; CASE REPORT; DISEASE ACTIVITY; DISEASE COURSE; DISEASE DURATION; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; DYSPNEA; ERYTHEMA; ERYTHROCYTE SEDIMENTATION RATE; FACE EDEMA; FEMALE; HAND EDEMA; HUMAN; HYPOTENSION; LIP; LOADING DRUG DOSE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SKIN MANIFESTATION; TREATMENT OUTCOME; TRUNK; URTICARIA;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; MIDDLE AGED; URTICARIA;

EID: 34147150251     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-005-0197-7     Document Type: Article

References (15)

1. O'Hollaren MT (1998) Update in allergy and immunology. Ann Intern Med 129:1036
2. Maini RN, Breedveld FC, Kalden JR et al (1998) Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 41:552-563
3. Maini R, St Clair EW, Breedveld F et al (1999) Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial. ATTRACT Study Group. Lancet 354:1932-1939
4. Moreland LW, Schiff MH, Baumgartner SW et al (1999) Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. Ann Intern Med 130:478-486
5. Mease P (2004) TNFα therapy in psoriatic arthritis and psoriasis: how and why does it work? Ann Rheum Dis 63:755-758
6. Gorman JD, Sack KE, Davis JC Jr (2002) Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N Engl J Med 346:1349-1356
7. Nikas SN, Alamanos Y, Voulgari PV, Pliakou XI, Papadopoulos CG, Drosos AA (2005) Infliximab therapy in ankylosing spondylitis: An observational study. Ann Rheum Dis 64:940-942
8. Devos SA, van den Bosche N, de Vos M, Naeyaert JM (2003) Adverse skin reactions to anti-TNF-α monoclonal antibody therapy. Dermatology 206:388-390
9. Beuthien W, Mellinghoff HU, von Kempis J (2004) Skin reaction to adalimumab. Arthritis Rheum 50:1690-1692
10. Stratigos AJ, Antoniou C, Stamathioudaki S, Avgerinou G, Tsega A, Katsambas AD (2004) Discoid lupus erythematosus-like eruption induced by infliximab. Clin Exp Dermatol 29:150-153
11. Jarrett SJ, Cunnane G, Conaghan PG, Bingham SJ, Buch MH, Quinn MA, Emery P (2003) Anti-tumor necrosis factor-alpha therapy-induced vasculitis: case series. J Rheumatol 30:2287-2291
12. Galaria NA, Werth VP, Schumacher HR (2000) Leukocytoclastic vasculitis due to etanercept. J Rheumatol 27:2041-2044
13. Brion PH, Mittal-Henkle A, Kalunian KC (1999) Autoimmune skin rashes associated with etanercept for rheumatoid arthritis. Ann Intern Med 131:634
14. Chan AT, Cleeve V, Daymond TJ (2002) Necrotising fasciitis in a patient receiving infliximab for rheumatoid arthritis. Postgrad Med J 78:47-48
15. Weinblatt ME, Keystone EC, Furst DE et al (2003) Adalimumab, a fully human anti-tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial. Arthritis Rheum 45:35-45